|Articles|April 1, 2011
- Pharmaceutical Executive-04-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - April 2011
A Silver Lining
Advertisement
Articles in this issue
over 14 years ago
iLogisticaover 14 years ago
Off-Label But On Point?over 14 years ago
Pharm Exec Wins a Neal Award!over 14 years ago
Espacio Riescoover 14 years ago
Restoring Public Trust in Pharmaover 14 years ago
HBA Woman of the Year: Freda Lewis-Hallover 14 years ago
Revisiting ReformNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
2
FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma
3
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
4
Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits
5